Cognitive Impairment Global Clinical Trials Review, H1, 2017

2017-06-30
Price :
Published : Jun-2017
No. of Pages : 435
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Cognitive Impairment to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Cognitive Impairment to Central Nervous System Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Cognitive Impairment Therapeutics Clinical Trials 35
Prominent Drugs 37
Clinical Trial Profile Snapshots 38
Appendix 433
Abbreviations 433
Definitions 433
Research Methodology 434
Secondary Research 434
About GlobalData 435
Contact Us 435
Source 435

List of Tables
Cognitive Impairment Therapeutics, Global, Clinical Trials by Region, 2017* 7
Cognitive Impairment Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 17
Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 22
Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
Cognitive Impairment Therapeutics, Global, Clinical Trials by Phase, 2017* 26
Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 27
Cognitive Impairment Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
Cognitive Impairment Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 32
Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

List of Figures
Cognitive Impairment Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Cognitive Impairment Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 16
Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 21
Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
Cognitive Impairment Therapeutics, Global, Clinical Trials by Phase (%), 2017* 26
Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 27
Cognitive Impairment Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
Cognitive Impairment Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 32
Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37
GlobalData Methodology 434
Filed in: Pharmaceutical
Publisher : GlobalData